CEACAM5 and neoplasm: At present, many serum tumour biomarkers (such as CA 19-9, CA 242, carcinoembryonic antigen (CEA), etc.) have been proposed for PC detection, even if the benefits of these biomarkers are unclear, since although sensitivity is increased, specificity is often not adequate (4).